Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies

DM Monti, G Ferraro, A Merlino - Nanomedicine: Nanotechnology, Biology …, 2019 - Elsevier
The encapsulation of anticancer metal-based drugs within a protein nanocage represents a
valuable strategy to improve the efficacy and selectivity of these compounds towards cancer …

Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies

DM Monti, G Ferraro, A Merlino - NANOMEDICINE, 2019 - iris.unina.it
The encapsulation of anticancer metal-based drugs within a protein nanocage represents a
valuable strategy to improve the efficacy and selectivity of these compounds towards cancer …

[引用][C] Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies

DM Monti, G Ferraro, A Merlino - … : Nanotechnology, Biology and …, 2019 - cir.nii.ac.jp
Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity
studies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies.

DM Monti, G Ferraro, A Merlino - … : Nanotechnology, Biology, and …, 2019 - europepmc.org
The encapsulation of anticancer metal-based drugs within a protein nanocage represents a
valuable strategy to improve the efficacy and selectivity of these compounds towards cancer …

Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies

DM Monti, G Ferraro, A Merlino - … , biology, and medicine, 2019 - pubmed.ncbi.nlm.nih.gov
The encapsulation of anticancer metal-based drugs within a protein nanocage represents a
valuable strategy to improve the efficacy and selectivity of these compounds towards cancer …